Observational studyEye (London, England)2026
Trocar sleeve adapter accelerates silicone oil injection in real-world vitreoretinal surgery.
Observational study in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Performance of a prototype electric silicone oil injector and aspirator in vitreoretinal surgery.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis retrospective, non-randomised, observational cohort study investigated the efficiency of a novel 23G trocar adapter to accelerate silicone oil (SO) injection during endotamponading vitreoretinal surgery. SUBJECTS: A total of 105 eyes were included consecutively. Only 23G procedures were eligible. Indications for SO injection were retinal detachment, recurrent retinal detachment, or SO exchange in eyes with retinal instability using either the high-flow viscous-fluid-extraction accessory cannula as the 23G trocar sleeve adapter (1362.VFE2, Dutch Ophthalmic Research Centre [DORC], Zuidland, the Netherlands; n
methodsPars plana vitrectomy was performed, and after complete fluid-air exchange, SO was injected. The trocar sleeve adapter group was treated with an injection pressure of 2.5 bar and with the trocar valve removed. The standard group was treated with 4 bar pressure and with the valve left in place. The time needed to achieve functionally complete filling of the vitreous cavity with SO was recorded. Safety outcomes included the number of device disconnection events and the occurrence of any major complications.
resultsMultiple linear regression analysis showed that the injection duration was significantly affected by SO type (β = 342.6, 95% confidence interval [CI]: 270.1-415.1, p < 0.0001), device type (β = 190.3, 95% CI: 117.2-263.5, p < 0.0001), and axial length (β = 40.3, 95% CI: 21.6-59.1, p < 0.0001). Application of the 23G trocar sleeve adapter significantly reduced the injection time needed to fill the vitreous cavity with Densiron 68, from 258.9 ± 74.7 s (PVC; 95% CI: 231.0-286.8; 241.5 ± 78 s [median ± interquartile range]) to 89.8 ± 55.0 s (95% CI: 69.3-110.4; 76.0 ± 50.5 s; p < 0.0001, Fisher's LSD, two-way ANOVA). For DORC Silicone 5000, a time reduction from 773.7 ± 257.7 s (95% CI: 631.0-916.4; 835.0 ± 332.0) to 152.8 ± 44.5 s was achieved (95% CI: 136.2-169.4; 153.0 ± 66.5; p < 0.0001, Fisher's LSD, two-way ANOVA). Comparisons of vitreous volume-adjusted injection durations calculated using the VIVEX formula yielded similar results (both p < 0.0001). Three disconnection events occurred, and all procedures were completed without major complications.
conclusionsAlthough the 23G trocar sleeve adapter was developed for SO extraction, it reduced the time required for low- and high-viscosity SO injection by three- and fivefold, respectively. The 23G trocar sleeve adapter thus has the potential to substantially shorten SO injection times in clinical practice, although randomised or crossover study designs will be required for validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.